@alfayezmo @subatomicdoc curious to see the Cochrane review for WBRT alongside http://t.co/daHs0XNh1l
@alfayezmo @subatomicdoc curious to see the Cochrane review for WBRT alongside http://t.co/daHs0XNh1l
@sabinbmotwanimd @drthomasklein 30gy in 10#, why not 20 in 5#? http://t.co/naEa86EJ8i #radonc
@Rad_Nation most common schedule for WBRT is 30 Gy 10#. Although no survival advantage over 20 Gy 5# #radonc http://t.co/rIZRVZrOCb
@Rad_Nation most common schedule for WBRT is 30 Gy 10#. Although no survival advantage over 20 Gy 5# #radonc http://t.co/rIZRVZrOCb
@Rad_Nation most common schedule for WBRT is 30 Gy 10#. Although no survival advantage over 20 Gy 5# #radonc http://t.co/rIZRVZrOCb
@Rad_Nation most common schedule for WBRT is 30 Gy 10#. Although no survival advantage over 20 Gy 5# #radonc http://t.co/rIZRVZrOCb
@Rad_Nation most common schedule for WBRT is 30 Gy 10#. Although no survival advantage over 20 Gy 5# #radonc http://t.co/rIZRVZrOCb
@DrMagicianEARL 全脳照射の参考文献です。症状がコントロールできれば良いですが。 http://t.co/jMMP34Y7nq
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases - http://t.co/Sdz5RIYSVG
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.: CONCLUSIONS: None of t... http://t.co/EBHt02RL
Whole brain radiotherapy for the treatment of newly diagnosed multiple brain metastases.: CONCLUSIONS: None of t... http://t.co/jY56eBcM